首页期刊导航|中华消化内镜杂志
期刊信息/Journal information
中华消化内镜杂志
中华医学会南京分会
中华消化内镜杂志

中华医学会南京分会

李兆申

月刊

1007-5232

xhnj@xhnj.com

025-83472831

210003

江苏省南京市紫竹林3号南京医学会

中华消化内镜杂志/Journal Chinese Journal of Digestive EndoscopyCSCD北大核心CSTPCD
查看更多>>1996年8月创刊，中华医学会主办。本刊原刊名《内镜》杂志。办刊宗旨是：贯彻党和国家的卫生工作方针、政策，注重理论与实际相结合，普及与提高相结合，报道国内外消化内镜学的最新进展，努力推动和促进我国消化内镜技术水平不断提高。《中华消化内镜杂志》主要报道内容包括食管镜、胃镜、十二指肠镜、胆囊镜和大肠镜、小肠镜、乙状结肠镜等领先的科研成果，及其设备、技术在国内外的进展，以及临床诊断和治疗经验等。目前的主要栏目有：论著、短篇论著、基础研究、临床报道、技术交流、特殊病例报道及内镜并发症等。读者对象为从事医疗、教学、科研等工作的消化系疾病及消化内镜工作者。
正式出版
收录年代

    中国肥胖症消化内镜治疗专家共识

    张澍田金震东令狐恩强李鹏...
    1-10页
    查看更多>>摘要：消化内镜减重手术是近年来在减重领域逐渐兴起的一项新兴学科，以其创伤小、恢复快、可逆性好、并发症少、性价比高的诸多优势为肥胖患者的治疗提供了一项新的解决方案，有望成为外科减重代谢手术的并行和补充疗法。基于现有的临床循证医学依据，中华医学会消化内镜学分会微创减重治疗协作组、中国医师协会消化医师分会减重专业委员会和国家消化系统疾病临床医学研究中心（北京）组织相关专家，对其适应证、禁忌证、技术操作规范和围手术期处理策略等方面进行讨论，并达成共识，旨在为消化内镜减重技术的规范开展提供参考和指导，促进中国减重学科的健康发展。 Endoscopic bariatric surgery is an emerging discipline in the field of weight loss in recent years. With the advantages of less trauma, faster recovery, better reversibility, fewer complications, and higher cost performance, endoscopic bariatric surgery provides an alternative for the treatment of obese patients. The new solution is expected to be a parallel and complementary therapy to surgical bariatric metabolic surgery. Based on the existing clinical evidence-based medicine, Minimally Invasive Weight Loss Treatment Collaboration Group of Digestive Endoscopy Branch of Chinese Medical Association, Weight Loss Professional Committee of Gastroenterology Physician Branch of Chinese Medical Doctor Association, and National Clinical Research Center for Digestive Diseases (Beijing) organized relevant experts to discuss its indications, contraindications, technical operating specifications, perioperative management strategies, etc., and reach a consensus, aiming to provide reference and guidance for the standardized development of endoscopic weight loss technology and promote the development of bariatric discipline in China.

    肥胖内镜减重微创减重胃内球囊内镜下袖状胃成形术

      原文链接:
    • 万方数据

    《中国肥胖症消化内镜治疗专家共识》解读

    隗永秋程芮李鹏张澍田...
    11-17页
    查看更多>>摘要：对《中国肥胖症消化内镜治疗专家共识》的出台背景以及需要关注的一些重点问题，如消化内镜减重手术的角色及指征界定、不同技术方案的选择及适用场景、围手术期的处理策略等进行解读。

    肥胖内镜减重微创减重胃内球囊内镜下袖状胃成形术解读

      原文链接:
    • 万方数据

    内镜下胃转流支架系统治疗肥胖的疗效和安全性分析

    周艳华张倩张澍田李鹏...
    18-24页
    查看更多>>摘要：目的 评价内镜下胃转流支架系统对肥胖患者体重和肥胖相关代谢指标的疗效，并评估设备的安全性。 方法 选取2021年3月至2022年10月全国多中心随机对照试验中于首都医科大学附属北京友谊医院行胃转流支架治疗的14例肥胖患者进行亚组分析。患者入组后行内镜下胃转流支架置入术，12周后经内镜取出，取出后继续随访至36周。主要评价入组12周、24周和36周患者的多余体重减少率、总体重减少率、胰岛素抵抗、转氨酶、血脂和尿酸的变化，以及设备的安全性。 结果 14例患者中男9例、女5例，年龄（34.3±7.4）岁，初始体重（104.8±13.9）kg。2例患者因不能耐受消化道不良反应提前取出支架，其余12例患者完成了随访，12周、24周和36周多余体重减少率分别为34.4%±25.5%、39.1%±37.5%和27.3%±40.8%；总体重减少率分别为8.7%±6.2%、10.1%±10.2%和8.3%±13.8%。胰岛素抵抗的稳态模型评估基线水平为7.03±3.59，12周时为4.81±3.71（与基线相比P=0.022），24周时为4.17±2.77（与基线相比P=0.002），36周时为4.66±3.58（与基线相比P=0.016）。丙氨酸转氨酶（alanine aminotransferase，ALT）在基线、12周、24周和36周分别为48（21~124）U/L、39（14~96）U/L、27（10~86）U/L和32（16~113）U/L，ALT下降在24周、36周差异均有统计学意义（与基线相比P=0.009，P=0.026）。天冬氨酸转氨酶（aspartate aminotransferase，AST）在基线、12周、24周和36周分别为30（20~62）U/L、24（15~72）U/L、22（11~56）U/L和26（13~74）U/L，AST下降在24周差异有统计学意义（与基线相比P=0.018）。而血脂、尿酸的变化无统计学意义（P>0.05）。唯一的严重不良事件是在支架取出过程中发生1例食管黏膜撕裂，经内镜下金属夹成功夹闭治疗。所有患者无器械移位、急性胰腺炎或肝脓肿等发生。 结论 胃转流支架系统短期内具有良好的减重效果，且相对安全，还可以改善胰岛素抵抗和肝酶。 Objective To evaluate the efficacy and safety of a gastric bypass stent system for weight loss and obesity-associated metabolic parameters. Methods A sub-analysis of a multicenter randomized control trial was conducted on data of 14 obese patients who were implanted the gastric bypass stent system under endoscopy in Beijing Friendship Hospital, Capital Medical University from March 2021 to October 2022. The device was removed after 12 weeks and the patients were followed up for 36 weeks. Outcomes included changes in excess weight loss (EWL), total weight loss (TWL), insulin resistance, liver enzymes, lipids and uric acid at 12, 24 and 36 weeks, and the safety of the device. Results Among the 14 patients, there were 9 males and 5 females, aged 34.3±7.4 years, with an initial body weight of 104.8±13.9 kg. Stents were removed in advance in 2 patients because of intolerable adverse reactions of the digestive tract. The remaining 12 patients completed follow-up, and their EWL was 34.4%±25.5% at 12 weeks, 39.1%±37.5% at 24 weeks, and 27.3%±40.8% at 36 weeks. TWL was 8.7%±6.2%, 10.1%±10.2% and 8.3%±13.8%, respectively. The levels of homeostasis model assessment of insulin resistance (HOMA-IR) at 12 weeks (4.81±3.71, P=0.022), 24 weeks (4.17±2.77, P=0.002) and 36 weeks (4.66±3.58, P=0.016) were statistically significant compared with baseline (7.03±3.59). The levels of alanine aminotransferase (ALT) were 48 (21-124) U/L, 39 (14-96) U/L, 27 (10-86) U/L and 32 (16-113) U/L at baseline, 12 weeks, 24 weeks and 36 weeks, respectively, and the changes of ALT were statistically significant at 24 weeks and 36 weeks (P=0.009, P=0.026 compared with baseline). The levels of aspartate aminotransferase (AST) were 30 (20-62) U/L, 24 (15-72) U/L, 22 (11-56) U/L and 26 (13-74) U/L at baseline, 12 weeks, 24 weeks and 36 weeks, respectively, and the change of AST was significant at 24 weeks (P=0.018 compared with baseline). However, the changes of uric acid and serum lipid were not statistically significant (P>0.05). The only severe adverse event was esophageal mucosal laceration during the process of explantation, which was successfully treated with endoscopic clips. There was no device migration, acute pancreatitis or hepatic abscess. Conclusion The gastric bypass stent system, relatively safe, has a good short-term weight loss effect and improves insulin resistance and liver enzymes.

    肥胖胃转流支架系统多余体重减少率总体重减少率安全性

      原文链接:
    • 万方数据

    新型便携式内镜系统用于动物腹部战创伤救治的可行性与安全性研究

    张婷邹文斌姜春晖王震...
    25-29页
    查看更多>>摘要：目的 比较新型便携式内镜系统和常规电子内镜系统用于动物腹部战创伤探查与紧急治疗的可行性与安全性。 方法 将3头健康巴马猪分别编为1号、2号、3号，术前禁食水8 h。实验前进行诱导麻醉，从巴马猪的中腹壁逐层切开进入腹腔，利用腹腔镜气腹机建立人工气腹，置入子弹模型1枚，建立子弹创伤模型；取出子弹模型后置入弹片模型1枚，建立弹片创伤模型。分别应用新型便携式内镜系统和常规电子内镜系统对1号巴马猪进行子弹模型和弹片模型的探查及取出操作。上述操作结束后，两种内镜系统分别对2号、3号巴马猪进行同样操作过程。两种内镜操作的先后顺序根据随机数表法进行分配。分别记录两种内镜系统的手术成功情况、手术时间、内镜管道通畅性、内镜操作满意情况、不良事件和器械缺陷发生情况。 结果 使用新型便携式内镜系统和常规电子内镜系统进行手术各3次，手术均成功。新型便携式内镜系统发现及取出子弹模型、发现及取出弹片模型的时间分别为（232.33±11.68）s、（300.33±57.70）s、（170.00±44.44）s、（52.67±2.52）s；常规电子内镜系统相应时间分别为［（232.67±21.20）s，t=-0.054，P=0.962］、［（256.67±67.00）s，t=0.880，P=0.472］、［（176.00±52.42）s，t=-0.111，P=0.922］、［（58.67±14.84）s，t=-0.832，P=0.493］，差异无统计学意义（P>0.05）。实验过程中，两种内镜系统管道均通畅，操作者对两种内镜系统的内镜操作过程均满意。两组均无不良事件和器械缺陷发生。 结论 新型便携式内镜系统用于动物腹部战创伤的救治操作成功情况与常规电子内镜系统相当，初步证实该系统用于动物腹部战创伤救治安全可行。 Objective To compare the feasibility and safety of a new portable endoscopic system and the conventional endoscopic system for the detection and emergency treatment of abdominal trauma in animal models. Methods Three healthy Bama pigs, which were fasted and water deprivation for 8 h before surgery and then underwent induction anesthesia. A layer-by-layer incision was made into the abdominal cavity of Bama pigs. An artificial pneumoperitoneum was established using a laparoscopic pneumoperitoneum machine. A bullet model was inserted into the abdominal cavity to build the bullet wound model. After the bullet model was removed, a shrapnel model was inserted into the mid-abdomen to build the shrapnel wound model. The two types of endoscopic system were used to detect, remove bullet model or shrapnel model of the three Bama pigs respectively. The procedure order of the two systems was assigned according to the random number table method. The surgical success, operation time, endoscopy pipeline patency, endoscopic operation satisfaction, adverse events and equipment defects were recorded. Results Three surgeries were performed using the new portable endoscopic system and three other surgeries using the conventional endoscopic system, all of which were successful. The time of the new portable endoscopic system to find and remove the bullet model, and the shrapnel model were 232.33±11.68 s, 300.33±57.70 s, 170.00±44.44 s and 52.67±2.52 s, respectively. The corresponding time of the conventional endoscopic system were 232.67±21.20 s (t=-0.054, P=0.962), 256.67±67.00 s (t=0.880, P=0.472), 176.00±52.42 s (t=-0.111, P=0.922), 58.67±14.84 s (t=-0.832, P=0.493), respectively. There was no significant difference between the two systems (P>0.05). The endoscopy tubes of the two endoscopic systems were both smooth. The operator was satisfied with the endoscopic procedures of both endoscopic systems, and no adverse event or device defect occurred. Conclusion The portable endoscopic system proves to be safe and feasible for the diagnosis and treatment of abdominal trauma in animal models.

    创伤和损伤便携式内镜腹部战创伤动物实验

      原文链接:
    • 万方数据

    早期胃癌内镜下非治愈性切除术后追加外科手术患者的临床结果分析

    王佳凤王鑫鑫关达王润梓...
    30-34页
    查看更多>>摘要：目的 分析早期胃癌内镜下非治愈性切除患者追加外科手术的必要性。 方法 回顾分析2009年7月至2023年5月于解放军总医院就诊的内镜下非治愈性切除术后追加外科手术的73例早期胃癌患者资料。主要观察指标包括术后标本病理类型、水平切缘情况、垂直切缘情况、标本浸润深度、是否脉管侵犯、eCura评分、阳性淋巴结例数以及总体生存率。 结果 73例被判定为内镜下非治愈性切除的早期胃癌患者均追加了外科手术，其中男58例、女15例，平均年龄61岁（53~67岁）。发病部位方面，37例位于胃上部，24例位于胃下部，11例位于胃中部，1例为多发部位病变。病理类型分型方面，43例为高中分化管状腺癌，16例为黏液/印戒细胞癌，10例为低分化管状腺癌，4例为高级别上皮内瘤变。根据巴黎分型，22例为0-Ⅱa型，43例为0-Ⅱb型，8例为0-Ⅲ型。浸润深度方面，17例为黏膜内癌，23例黏膜下侵犯不足500 μm，33例黏膜下侵犯超过500 μm。脉管浸润方面，8例存在淋巴管侵犯，8例存在静脉侵犯。73例患者中，4例被判断为eCura A，5例为eCura B，4例为eCura C1，60例为eCura C2。在60例被判断为eCura C2的患者中，根据外科术后病理标本评估，仅2例（3.3%）发现存在胃周淋巴结转移。73例内镜下标本中，7例患者水平切缘阳性，21例垂直切缘阳性，2例水平及垂直切缘均为阳性，总计30例患者存在水平或垂直切缘阳性，根据外科术后病理标本评估，9例（30.0%）发现原部位肿瘤残留。73例患者中，5例失访，4例死亡，总体生存率为94.12%（64/68），疾病特异生存率98.53%（67/68），患者随访时间为61.37（10~166）个月。 结论 对于内镜下非治愈性切除评估结果为eCura C2的早期胃癌患者，追加手术是可行的，但是实际存在淋巴结转移的患者比例较低。 Objective To analysis the necessity of additional surgical intervention for non-curative endoscopic resection patients with early gastric cancer. Methods A retrospective analysis was conducted on 73 patients with early gastric cancer who underwent additional surgical procedures after non-curative endoscopic resection at Chinese PLA General Hospital from July 2009 to May 2023. The main outcome measures included pathological classification, positive horizontal margins, positive vertical margins, invasion depth, vascular and lymphatic invasion, eCura grade, lymph node metastasis, and overall survival rate. Results A total of 73 patients with early gastric cancer who were determined to have non-curative endoscopic resection underwent additional surgical procedures, including 58 males and 15 females with a mean age of 61 (53-67) years. In terms of the site of onset, 37 cases were located in the upper part of the stomach, 24 cases in the lower part, 11 cases in the middle part, and 1 case had multiple lesions. In terms of pathological classification, 43 cases were highly differentiated tubular adenocarcinoma, 16 cases were mucinous/signet ring cell carcinoma, 10 cases were poorly differentiated tubular adenocarcinoma, and 4 cases were high-grade intraepithelial neoplasia. In terms of morphological classification, 22 cases were type 0-Ⅱa, 43 cases were type 0-Ⅱb, and 8 cases were type 0-Ⅲ. In terms of invasion depth, 17 cases were mucosal cancer, 23 cases had submucosal invasion less than 500 μm, and 33 cases had submucosal invasion more than 500 μm. In terms of vascular and lymphatic invasion, 8 cases had lymphatic vessel invasion and 8 cases had venous invasion. Among the 73 patients, 4 were diagnosed as having eCura A, 5 as eCuraB, 4 as eCura C1, and 60 as eCura C2. Among the 60 patients diagnosed as having eCura C2, only 2 cases (3.3%) were found to have lymph node metastasis around the stomach based on postoperative pathological evaluation. Among the 73 endoscopic specimens, 7 patients had positive horizontal margins, 21 had positive vertical margins, and 2 had positive margins in both directions, totaling 30 patients with positive horizontal or vertical margins. According to postoperative pathological evaluation, 9 cases (30.0%) had residual tumors in the original site. Among the 73 patients, 5 were lost to follow-up and 4 died, resulting in an overall survival rate of 94.12% (64/68) and disease-specific survival rate of 98.53% (67/68). The follow-up time of patients was 61.37 (10-166) months. Conclusion For early gastric cancer patients with eCura C2 following non-curative endoscopic resection, additional surgery is feasible. However, the proportion of patients with actual lymph node metastasis is relatively low.

    胃肿瘤早期胃癌非治愈性切除淋巴结转移补救性切除假阳性切缘

      原文链接:
    • 万方数据

    机器人消化内镜系统的研制及机械模型与活体动物实验研究（含视频）

    刘冰熔付宜利刘凯鹏李德亮...
    35-42页
    查看更多>>摘要：目的 研制机器人消化内镜系统（robotic digestive endoscope system，RDES），验证其可行性、安全性及操控性能。 方法 基于主从控制系统设计RDES，包含3部分：整合内镜主体包括内镜和与之整合的内镜旋钮/按钮控制系统；机械臂系统包括基座、机械臂及连接在其上的内镜进退操控装置（有力反馈）和内镜轴向旋转操控装置；操控台包括内镜控制主手和图像显示器。操作者坐在远离检查台的操控台前，操控主手实现内镜头端弯曲、镜身进退及旋转，并通过主手上的按钮实现送气、送水、吸引、定图以及运动比切换功能。（1）活体猪胃镜检查实验：初学组、高级组医师各5名，每人分别操控RDES及普通内镜（间隔2周）行活体猪胃镜检查6次，比较检查时间。（2）仿真胃模型内壁画圆实验：初学组、高级组医师各5名，每人分别操控RDES 1∶1、RDES 5∶1模式和普通内镜完成画圆实验各6次，比较3种方式完成时间、准确度（即轨迹偏差）和工作量。 结果 RDES运行良好，力反馈良好。活体猪胃镜检查实验中，胃镜检查均顺利完成，无黏膜损伤及出血、穿孔。初学组和高级组医师操控RDES的检查时间均随操控例次增加呈下降趋势，但操控RDES的下降值大于操控普通内镜（初学组P=0.033；高级组P=0.023）。仿真胃模型内壁画圆实验中，初学组医师操控RDES 1∶1、5∶1模式完成内镜下画圆时间均短于普通内镜［1.68（1.40，2.17）min、1.73（1.47，2.37）min比4.13（2.27，5.16）min，H=32.506，P<0.001］，轨迹偏差均优于普通内镜［（0.50±0.11）mm、（0.46±0.11）mm比（0.82±0.26）mm，F=38.999，P<0.001］，工作量均小于普通内镜［42.00（30.00，50.33）分、43.33（35.33，54.00）分比52.67（48.67，63.33）分，H=20.056，P<0.001］；高级组医师操控RDES 1∶1、5∶1模式完成时间均长于普通内镜［1.72（1.37，2.53）min、1.57（1.25，2.58）min比1.15（0.86，1.58）min，H=13.233，P=0.001］，但轨迹偏差［0.47（0.13，0.57）mm、0.44（0.39，0.58）mm比0.52（0.42，0.59）mm，H=3.202，P=0.202］、工作量［（44.62±21.77）分、（41.24±12.57）分比（44.71±17.92）分，F=0.369，P=0.693］和普通内镜差异无统计学意义。 结论 RDES可实现远台操控，大大降低了工作强度；RDES可同时调控大小旋钮，使操控更灵活；RDES增加了运动比模式，使操控更精细；RDES易于初学者掌握，有望缩短医师培养周期；RDES为实现内镜远程操控和全自动消化内镜提供了可能。 Objective To develop a robotic digestive endoscope system (RDES) and to evaluate its feasibility, safety and control performance by experiments. Methods The RDES was designed based on the master-slave control system, which consisted of 3 parts: the integrated endoscope, including a knob and button robotic control system integrated with a gastroscope the robotic mechanical arm system, including the base and arm, as well as the endoscopic advance-retreat control device (force-feedback function was designed) and the endoscopic axial rotation control device the control console, including a master manipulator and an image monitor. The operator sit far away from the endoscope and controlled the master manipulator to bend the end of the endoscope and to control advance, retract and rotation of the endoscope. The air supply, water supply, suction, figure fixing and motion scaling switching was realized by pressing buttons on the master manipulator. In the endoscopy experiments performed on live pigs, 5 physicians each were in the beginner and advanced groups. Each operator operated RDES and traditional endoscope (2 weeks interval) to perform porcine gastroscopy 6 times, comparing the examination time. In the experiment of endoscopic circle drawing on the inner wall of the simulated stomach model, each operator in the two groups operated RDES 1∶1 motion scaling, 5∶1 motion scaling and ordinary endoscope to complete endoscopic circle drawing 6 times, comparing the completion time, accuracy (i.e. trajectory deviation) and workload. Results RDES was operated normally with good force feedback function. All porcine in vivo gastroscopies were successful, without mucosal injury, bleeding or perforation. In beginner and advanced groups, the examination time of both RDES and ordinary endoscopy tended to decrease as the number of operations increased, but the decrease in time was greater for operating RDES than for operating ordinary endoscope (beginner group P=0.033 advanced group P=0.023). In the beginner group, the operators operating RDES with 1∶1 motion scaling or 5∶1 motion scaling to complete endoscopic circle drawing had shorter completion time [1.68 (1.40, 2.17) min, 1.73 (1.47, 2.37) min VS 4.13 (2.27, 5.16) min, H=32.506, P<0.001], better trajectory deviation (0.50±0.11 mm, 0.46±0.11 mm VS 0.82±0.26 mm,F=38.999, P<0.001], and less workload [42.00 (30.00, 50.33) points, 43.33 (35.33, 54.00) points VS 52.67 (48.67, 63.33) points,H=20.056, P<0.001] than operating ordinary endoscope. In the advanced group, the operators operating RDES with 1∶1 or 5∶1 motion scaling to complete endoscopic circle drawing had longer completion time than operating ordinary endoscope [1.72 (1.37, 2.53) min, 1.57 (1.25, 2.58) min VS 1.15 (0.86, 1.58) min,H=13.233, P=0.001], but trajectory deviation [0.47 (0.13, 0.57) mm, 0.44 (0.39, 0.58) mm VS 0.52 (0.42, 0.59) mm, H=3.202, P=0.202] and workload (44.62±21.77 points, 41.24±12.57 points VS 44.71±17.92 points, F=0.369, P=0.693) were not different from those of the ordinary endoscope. Conclusion The RDES enables remote control, greatly reducing the endoscopists' workload. Additionally, it gives full play to the cooperative motion function of the large and small endoscopic knobs, making the control more flexible. Finally, it increases motion scaling switching function to make the control of endoscope more flexible and more accurate. It is also easy for beginners to learn and master, and can shorten the training period. So it can provide the possibility of remote endoscopic control and fully automated robotic endoscope.

    内窥镜检查,消化系统主从控制系统机器人消化内镜系统第五代消化内镜

      原文链接:
    • 万方数据

    中国门静脉高压食管胃静脉曲张内镜治疗现状调研分析

    王省胡兵李异玲冯志杰...
    43-51页
    查看更多>>摘要：目的 全面了解我国门静脉高压食管胃静脉曲张内镜治疗的现状，为我国内镜治疗的发展提供数据支持和参考。 方法 本研究由中国肝脏健康联盟（Liver Health Consortium in China，CHESS）发起，通过网络分发调查问卷了解2022年国内开展门静脉高压食管胃静脉曲张内镜治疗的基本情况。问卷问题主要包括各类内镜治疗例数和适应证，依照指南预防食管胃静脉曲张出血（esophagogastric variceal bleeding，EGVB）的依从性，急性EGVB的处理、治疗时机，胃底及特殊类型静脉曲张的处理、内镜治疗的改善等方面。统计各项治疗数据的医院数量占参与调查问卷医院数量的比例，各级医院的指南依从性比较使用卡方检验进行分析。 结果 31个省（自治区、直辖市）共836家医院参与本调研，调查显示内镜治疗的主要适应证是控制急性出血（49.3%，412/836）和预防再出血（38.3%，320/836）。参与调研医院对于我国指南中EGVB一级预防的推荐意见（非选择性β受体阻滞剂或内镜治疗）的依从性为72.5%（606/836），对于EGVB二级预防推荐意见（非选择性β受体阻滞剂联合内镜治疗）的依从性为39.2%（328/836），三级医院和二级医院对于一级预防［71.0%（495/697）比79.9%（111/139），χ2=4.11，P=0.033］和二级预防的依从性［41.6%（290/697）比27.3%（38/139），χ2=9.31，P=0.002］差异有统计学意义。78.2%（654/836）的医院首选内镜治疗处理急性EGVB，三级医院首选内镜治疗的比例明显高于二级医院［82.6%（576/697）比56.1%（78/139），χ2=46.33，P<0.001］。治疗时机通常为出血后12 h内（48.5%，317/654）和12~24 h（36.9%，241/654）。对于近贲门大弯侧的胃底静脉曲张和孤立性胃静脉曲张，分别有48.2%（403/836）和29.9%（250/836）的医院首选组织胶联合硬化剂注射进行处理，而12.4%（104/836）和26.4%（221/836）的医院首选以止血夹为基础的内镜治疗术式。参与调研医院认为提高内镜医师水平（84.2%，704/836）和对患者进行准确的术前评估并提高多学科诊疗水平（78.9%，660/836）是当前内镜治疗急需改进的方面。 结论 多种门静脉高压食管胃静脉曲张内镜治疗技术已在全国范围广泛开展，各级医院在开展急诊内镜进行EGVB止血方面较为积极，但对于预防EGVB首次出血和再出血方面的指南依从性欠佳。参与调研医院在胃静脉曲张的内镜治疗选择方面差异较大。 Objective To investigate the current status of endoscopic treatment for gastroesophageal varices in portal hypertension in China, and to provide supporting data and reference for the development of endoscopic treatment. Methods In this study, initiated by the Liver Health Consortium in China (CHESS), a questionnaire was designed and distributed online to investigate the basic condition of endoscopic treatment for gastroesophageal varices in portal hypertension in 2022 in China. Questions included annual number and indication of endoscopic procedures, adherence to guideline for preventing esophagogastric variceal bleeding (EGVB), management and timing of emergent EGVB, management of gastric and isolated varices, and improvement of endoscopic treatment. Proportions of hospitals concerning therapeutic choices to all participant hospitals were calculated. Guideline adherence between secondary and tertiary hospitals were compared by using Chi-square test. Results A total of 836 hospitals from 31 provinces (anotomous regions and municipalities) participated in the survey. According to the survey, the control of acute EGVB (49.3%, 412/836) and the prevention of recurrent bleeding (38.3%, 320/836) were major indications of endoscopic treatment. For primary [non-selective β-blocker (NSBB) or endoscopic therapies] and secondary prophylaxis (NSBB and endoscopic therapies) of EGVB, adherence to domestic guideline was 72.5% (606/836) and 39.2% (328/836), respectively. There were significant differences in the adherence between secondary and tertiary hospitals in primary prophylaxis of EGVB [71.0% (495/697) VS 79.9% (111/139), χ2=4.11, P=0.033] and secondary prophylaxis of EGVB [41.6% (290/697) VS 27.3% (38/139), χ2=9.31, P=0.002]. A total of 78.2% (654/836) hospitals preferred endoscopic therapies treating acute EGVB, and endoscopic therapy was more likely to be the first choice for treating acute EGVB in tertiary hospitals (82.6%, 576/697) than secondary hospitals [56.1% (78/139), χ2=46.33, P<0.001]. The optimal timing was usually within 12 hours (48.5%, 317/654) and 12-24 hours (36.9%, 241/654) after the bleeding. Regarding the management of gastroesophageal varices type 2 and isolated gastric varices type 1, most hospitals used cyanoacrylate injection in combination with sclerotherapy [48.2% (403/836) and 29.9% (250/836), respectively], but substantial proportions of hospitals preferred clip-assisted therapies [12.4% (104/836) and 26.4% (221/836), respectively]. Improving the skills of endoscopic doctors (84.2%, 704/836), and enhancing the precision of pre-procedure evaluation and quality of multidisciplinary team (78.9%, 660/836) were considered urgent needs in the development of endoscopic treatment. Conclusion A variety of endoscopic treatments for gastroesophageal varices in portal hypertension are implemented nationwide. Participant hospitals are active to perform emergent endoscopy for acute EGVB, but are inadequate in following recommendations regarding primary and secondary prophylaxis of EGVB. Moreover, the selection of endoscopic procedures for gastric varices differs greatly among hospitals.

    门静脉高压食管和胃静脉曲张内镜治疗套扎硬化剂组织胶问卷调查指南依从性

      原文链接:
    • 万方数据

    胃食管阀瓣异常与贲门息肉发生相关性的回顾性病例对照研究

    张桓语姜鑫刘邦杰缪子庭...
    52-57页
    查看更多>>摘要：目的 探讨贲门息肉的发生与胃食管阀瓣（gastroesophageal flap valve，GEFV）的相关性。 方法 回顾性收集2016年1月1日至2021年12月31日在扬州大学附属医院就诊的349例贲门息肉患者（贲门息肉组）的临床、内镜及病理资料，根据倾向性评分匹配同期相同例数的非贲门息肉患者（非贲门息肉组）作为对照，对比分析两组的临床、内镜及组织病理资料。 结果 倾向性评分匹配后，贲门息肉组与非贲门息肉组各296例患者，两组在吸烟、反酸、烧心、幽门螺杆菌感染、胆汁反流、反流性食管炎、贲门炎方面差异均无统计学意义（P>0.05），两组间具有可比性。与非贲门息肉组相比，GEFV Ⅱ级患者（OR=3.046，95%CI：2.100~4.419，P<0.001）与GEFV Ⅲ级患者（OR=4.202，95%CI：2.299~7.681，P<0.001）发生贲门息肉风险增加。且与非贲门息肉组相比，GEFV异常患者发生贲门息肉风险增加（OR=2.822，95%CI：1.615~4.931，P<0.001）。GEFV异常与贲门息肉部位相关（χ2=22.169，P=0.003），与贲门息肉大小、数目、形态、周围黏膜肠化及上皮内瘤变无明显相关（P>0.05）。 结论 贲门息肉的发生与GEFV相关，GEFV异常患者更容易发生贲门息肉。 Objective To investigate the correlation between cardiac polyps and gastroesophageal flap valve (GEFV). Methods The clinical, endoscopic and pathological data of 349 patients with cardiac polyps (the cardiac polyp group) visiting Affiliated Hospital of Yangzhou University from January 1, 2016 to December 31, 2021 were retrospectively collected, and the same number of non-cardiac polyp patients (the non-cardiac polyp group) were matched in the same period as control according to the propensity score. The clinical, endoscopic and pathological data of the two groups were compared. Results After matching with propensity score, there were 296 patients in each group, with no significant differences in smoking, acid reflux, heartburn, Helicobacter pylori infection, bile reflux, reflux esophagitis or pancreatitis between the two groups (P>0.05). Compared with the non-cardiac polyp group, the risk of cardiac polyps increased in GEFV Ⅱ patients (OR=3.046, 95%CI: 2.100-4.419, P<0.001) and GEFV Ⅲ patients (OR=4.202, 95%CI: 2.299-7.681, P<0.001). Compared with the non-cardiac polyp group, the risk of cardiac polyps increased in patients with GEFV abnormalities (OR=2.822, 95%CI: 1.615-4.931,P<0.001). GEFV abnormalities was associated with the cardiac polyp site (χ2=22.169, P=0.003) and was not significantly associated with cardiac polyp size, number, morphology, intestinal metaplasia of the surrounding mucosa or intraepithelial neoplasia (P>0.05). Conclusion The occurrence of cardiac polyps is related to GEFV, and the patients with GEFV abnormalities are more likely to develop cardiac polyps.

    息肉贲门息肉胃食管阀瓣倾向性评分匹配

      原文链接:
    • 万方数据

    内镜下放射状切开术治疗儿童十二指肠隔膜狭窄13例临床分析（含视频）

    任晓侠杨洪彬葛库库张含花...
    58-64页
    查看更多>>摘要：目的 探讨内镜下放射状切开术（endoscopic radial incision，ERI）治疗儿童先天性十二指肠隔膜狭窄（membranous duodenal stenosis，MDS）的有效性及安全性。 方法 回顾性分析2017年5月至2021年12月西安市儿童医院消化内科收治的13例接受ERI治疗的MDS患儿的临床资料，分析手术过程、术后并发症及随访情况。 结果 13例MDS患儿中男5例，女8例，中位病程时间8个月（2~20个月），中位诊断月龄13个月（5~30个月）。隔膜位于十二指肠降部10例（10/13），水平部3例（3/13）。十二指肠乳头开口于隔膜上1例（1/13），隔膜口侧5 cm内3例（3/13），隔膜肛侧5 cm内9例（9/13）。隔膜中位孔径为3 mm（2~6 mm）。13例患儿均顺利完成ERI，中位手术时间20 min（15~32 min）。手术平均切开3刀（2~4刀），术后外径9.9 mm内镜可自由通过，切开中位直径10 mm（10~12 mm），术后临床症状均达到缓解。术后出现并发症1例（1/13），为切口迟发性出血，内镜下金属夹夹闭止血，无肠穿孔及十二指肠乳头损伤等并发症。术后中位住院时间为6 d（5~10 d）。术后3个月复查上消化道造影及胃镜，狭窄口中位直径12 mm（10~15 mm），较术前狭窄口明显扩张。术后1个月患儿体重比术前平均增加1.20 kg（0.50~1.80 kg），术后3个月患儿体重平均增加3.50 kg（2.50~4.00 kg），接近正常同龄儿标准体重。 结论 ERI作为微创方法治疗儿童MDS安全有效，具有良好的临床应用及推广价值。 Objective To explore the efficacy and safety of endoscopic radial incision (ERI) for congenital membranous duodenal stenosis (MDS). Methods The clinical data of 13 children with MDS receiving ERI in the Department of Gastroenterology of Xi'an Children's Hospital from May 2017 to December 2021 were reviewed and analyzed. The perioperative management, surgical procedures, postoperative complications and follow-up were summarized. Results There were 5 boys and 8 girls with a median disease duration of 8 (2-20) months, and the median age of diagnosis was 13 months (5-30 months). The septum of 10 cases (10/13) was located in the descending part of the duodenum, and that of 3 cases (3/13) in the horizontal part. The papilla of 1 case (1/13) opened on the septum, that of 3 cases (3/13) within 5 cm of the mouth side of the septum, and that of 9 cases (9/13) within 5 cm of the anal side of the septum. The median diameter of the septal aperture was 3 mm (2-6 mm). All 13 children successfully underwent ERI with a median operation time of 20 min (15-32 min). The average surgical incision was 3 strokes (2-4 strokes), and the endoscope with outer diameter 9.9 mm could pass stenosis after ERI. The median incision diameter was 10 mm (10-12 mm). All patients achieved relief of clinical symptoms after ERI. One patient (1/13) suffered from the postoperative delayed bleeding, which was stopped by endoscopic titanium clamping. No intestinal perforation or duodenal papilla injury occurred, and median postoperative hospital stay was 6 days (5-10 days). The upper gastrointestinal angiogram and gastroscopy were repeated 3 months after ERI, and the median diameter of stenosis was 12 mm (10-15 mm), which was significantly dilated compared with before. The mean body weight increase at 1 month after ERI was 1.20 kg (0.50-1.80 kg), and the mean body weight increase at 3 months was 3.50 kg (2.50-4.00 kg), which reached the normal body weight of the same age. Conclusion ERI is safe and effective for the treatment of MDS in children, and shows good clinical application and promotion value.

    十二指肠梗阻儿童十二指肠隔膜狭窄内镜下放射状切开术

      原文链接:
    • 万方数据

    内镜黏膜下剥离术中8字环辅助牵引的效果及安全性初探

    朱丹丹窦晓坛郭慧敏陈敏...
    65-67页
    查看更多>>摘要：为了评价内镜黏膜下剥离术（endoscopic submucosal dissection，ESD）中使用8字环辅助牵引的效果及安全性，2021年7月至2022年1月间，因胃部病变在南京大学医学院附属鼓楼医院行8字环辅助牵引下ESD治疗的总共13例病例（共15处病灶）纳入回顾性分析，结果显示13例均成功完成8字环辅助牵引下ESD，中位手术时间56 min，单位时间切除面积（0.20±0.02）cm2/min，病灶整块切除率93.3%（14/15），完全切除率80.0%（12/15），治愈性切除率80.0%（12/15），无术中及术后穿孔，无迟发性出血，无其他严重并发症及死亡病例。初步结果提示，8字环辅助牵引作为一种新型内牵引技术，操作简便，能够有效提高剥离效率，减少并发症发生，值得临床进一步研究和推广。 To evaluate the effectiveness and safety of 8-ring assisted traction in endoscopic submucosal dissection (ESD), a total of 13 patients with 15 gastric lesions who underwent 8-ring traction-assisted ESD in Nanjing Drum Tower Hospital from July 2021 to January 2022 were included in the retrospective cohort study. All patients successfully completed the operation. The median procedure time was 56 min, and the dissected area per unit time was 0.20±0.02 cm2/min. The en bloc resection rate, the complete resection rate and the curative resection rate were 93.3% (14/15), 80.0% (12/15) and 80.0% (12/15), respectively. There were no ESD-related complications, such as delayed bleeding or intraperative and postoperative perforation. No deaths occurred. As a novel internal traction technology, 8-ring traction method is simple to operate, providing a good field of vision during ESD to improve the dissection efficiency and reduce complications, which is worthy of further clinical research and promotion.

    胃肠内窥镜内镜黏膜下剥离术辅助牵引8字环

      原文链接:
    • 万方数据